Status:
RECRUITING
PVP-Guided Decongestive Therapy in HF 2
Lead Sponsor:
Başakşehir Çam & Sakura City Hospital
Collaborating Sponsors:
Ankara Etlik City Hospital
Akdeniz University
Conditions:
Heart Failure
Congestion
Eligibility:
All Genders
18-99 years
Phase:
PHASE4
Brief Summary
The investigators hypothesize that a simple assessment of peripheral venous pressure (PVP) will better predict the diuretic need and long-term outcomes (all cause mortality, all cause rehospitalizatio...
Detailed Description
I. BACKGROUND AND SIGNIFICANCE Precise assessment of volume status is essential in diagnosis and management of diuretic therapy in patients hospitalized for heart failure (HF). Unfortunately, no clea...
Eligibility Criteria
Inclusion
- Inclusion criteria
- Hospitalization for heart failure (de novo or decompensated chronic heart failure) irrespective of left ventricular ejection fraction
- Age 18-99
- Accept to participate
- Exclusion criteria
- A prior history of upper extremity venous disease
- Serum creatinine ≥ 3.5 mg/dL
- Severe stenotic valvular disease
- Hypertrophic obstructive cardiomyopathy
- Withdrawal of consent
- Indwelling central venous catheter,
- Implanted left ventricular assist device
- History of heart transplantation
- Clinical diagnosis of cardiogenic shock
- Any right-to-left shunt
Exclusion
Key Trial Info
Start Date :
July 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2026
Estimated Enrollment :
650 Patients enrolled
Trial Details
Trial ID
NCT06495892
Start Date
July 1 2024
End Date
July 1 2026
Last Update
December 4 2024
Active Locations (16)
Enter a location and click search to find clinical trials sorted by distance.
1
Ankara Etlik City Hospital
Ankara, Turkey (Türkiye), 6010
2
Antalya Atatürk State Hospital
Antalya, Turkey (Türkiye), 07040
3
Akdeniz University
Antalya, Turkey (Türkiye), 07070
4
Trakya University
Edirne, Turkey (Türkiye), 22030